Evidence map›Paper›PMID 39072710›Full record

ArticleCancer2024

Role of primary care in opioid prescribing for older head and neck cancer survivors.

Talya Salz, Akriti Mishra Meza, Patrick T Bradshaw, Sankeerth Jinna, Natalie Moryl, Anuja Kriplani, Kathryn R Tringale, James Flory, Deborah Korenstein, Allison Lipitz-Snyderman

Abstract read
In one paragraph

Article in Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Talya SalzMemorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID https://orcid.org/0000-0002-4515-6004
Akriti Mishra MezaMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Patrick T BradshawUniversity of California Berkeley, Berkeley, California, USA.
Sankeerth JinnaMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Natalie MorylMemorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID https://orcid.org/0000-0001-9097-3620
Anuja KriplaniMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Kathryn R TringaleUniversity of California San Diego School of Medicine, San Diego, California, USA.
James FloryMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Deborah KorensteinMount Sinai Hospital, New York, New York, USA.
Allison Lipitz-SnydermanMemorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID https://orcid.org/0000-0003-2423-2220

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS HHSN261201800009CNCI NIH HHS HHSN261201800009INCI NIH HHS HHSN261201800015CNCI NIH HHS HHSN261201800015INCI NIH HHS HHSN261201800032CNCI NIH HHS HHSN261201800032INCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundOlder head and neck cancer (HNC) survivors have concerning rates of potentially unsafe opioid prescribing. Identifying the specialties of opioid prescribers for HNC survivors is critical for targeting the settings for opioid safety interventions. This study hypothesized that oncology and surgery providers are primarily responsible for opioid prescriptions in the year after treatment but that primary care providers (PCPs) are increasingly involved in prescribing over time.

methodsUsing linked Surveillance, Epidemiology, and End Results-Medicare data, a retrospective analysis was conducted of adults aged >65 years diagnosed between 2014 and 2017 with stage I-III HNC and who had ≥6 months of treatment-free follow-up through 2019. Starting at treatment completion, opioid fills were assigned to a prescriber specialty: oncology, surgery, primary care, pain management, or other. Prescriber patterns were summarized for each year of follow-up. Multinomial logistic regression models captured the likelihood of opioids being prescribed by each specialty.

resultsAmong 5135 HNC survivors, 2547 (50%) had ≥1 opioid fill (median, 2.1-year follow-up). PCPs prescribed 47% of all fills (42%-55% each year). PCPs prescribed opioids to 45% of survivors with ≥1 opioid fill, which was a greater share than other specialties. PCPs prescribed longer supplies of opioids (median, 20 days/fill; median, 30 days/year) than oncologists or surgeons. The likelihood of an opioid being prescribed by an oncology provider was four times lower than that of it being prescribed by a PCP.

conclusionsPCP involvement in opioid prescribing remains high throughout HNC survivorship. Interventions to improve the safety of opioid prescribing should target primary care, as is typical for opioid reduction efforts in the noncancer population.

Indexed as

Analgesics, OpioidCancer SurvivorsHead and Neck NeoplasmsPractice Patterns, Physicians'Primary Health CareAgedAged, 80 and overDrug PrescriptionsFemaleHumansMaleMedicarePain ManagementRetrospective StudiesSEER ProgramUnited StatesAnalgesics, Opioidanalgesicscancer survivorshead and neck neoplasmsopioidpain managementprimary health care

Identifiers

PMID39072710
PMCPMC11511644

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.